Roth MKM lowered the firm’s price target on Tilly’s (TLYS) to $2.50 from $5 and keeps a Neutral rating on the shares. The company’s Q4 results ...

In a report released today, Gerry Sweeney from Roth MKM maintained a Buy rating on Allient (ALNT – Research Report), with a price target of ...

D-Wave Quantum, Inc. (QBTS) stock has bucked the broader market downturn seen this week thanks to two key catalysts. The ...

Analysts expect the Broomfield, Colorado-based company to report quarterly earnings at 9 cents per share, down from 11 cents ...

Roth Capital issued their Q1 2025 earnings estimates for Fortress Biotech in a research report issued on Tuesday, March 11th. Roth Capital analyst J. Wittes forecasts that the biopharmaceutical ...

About ROTH MKM ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors.

Detailed price information for Cyberark Soft Ord (CYBR-Q) from The Globe and Mail including charting and trades.

On Friday, Roth/MKM analysts reinstated coverage on PLBY Group, Inc. (NASDAQ: PLBY) with a Buy rating and set a price target of $3.00, representing significant upside from the current price of $1.66.

Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on Longeveron (LGVN – Research Report) today and set a price target of $10.00. The company’s shares closed today ...

Credo Technology Group (NASDAQ:CRDO) issued its third-quarter earnings report on Tuesday. It reported quarterly earnings of ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and ...